Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
Orascom Telecom Holding (C): Condensed
Bourgeois, L. J. IIICaso DARDEN-S-0246 -EDirección estratégicaDesde 5,74 €
-
Airbus vs. Boeing: (A), (B), (C), (D), (E), and (F), Teaching Note
Casadesus-Masanell, Ramon; Voigt, Erich Alexander; Mitchell, JordanNota del Instructor HBS-710405-EDirección estratégicaTeaching Note for [707447], [707448], [707449]. [707450], [707451], and [707452].Desde 0,00 €
-
Competir mediante modelos de negocio (C): Interdependencia, interacción táctica e interacción estratégica
Casadesus-Masanell, Ramon; Ricart Costa, Joan EnricCaso HBS-711S24Dirección estratégicaDesde 5,74 €
-
Betfair (B), (C), and (D) Case Slides
Casadesus-Masanell, Ramon; Heilbron, JohnCaso HBS-717520-EDirección estratégicaContains slides related to the Betfair B, C, and D cases.Desde 5,74 €
-
Titan Products, Inc.: Acquisition of Franz Schuler GMBH (C)
Bourgeois, L. J. III; Watson, DanCaso DARDEN-BP-0560-EGobierno corporativoThe C case is a memo from the head of Titan Products to Franz Schuler managment stating it is imperative that the R&D portion of Franz Schuler be kept separate from Titan and remain under the leadership of Hermann Schuler.Desde 5,74 €
-
Betfair (C)
Casadesus-Masanell, Ramon; Heilbron, John; Campbell, NeilCaso HBS-717518-EDirección estratégicaPrompted by a takeover bid from CVC, Betfair reassesses the strengths and weaknesses of the exchange model.Desde 5,74 €
-
Imprimis (C)
Casadesus-Masanell, Ramon; Elterman, Karen; Appel, MarcCaso HBS-717497-EIniciativa emprendedoraThis case is a supplement to Imprimis (Case A) and Imprimis (Case B). Set in 2015, it first describes Imprimis's decision to introduce its own line of compounded eye drop medication called LessDrops. The case then examines the moral dilemma faced by CEO Mark Baum, who was struck by the problem of high drug prices in the United States. Recent, drastic price hikes on pharmaceutical drugs, such as those initiated by Turing Pharmaceuticals under CEO ...Desde 5,74 €
-
Launching Telmore (C)
Casadesus-Masanell, Ramon; Fernandez, Celso; Jobke, MoritzCaso HBS-708416-EDirección estratégicaSupplement to the (A) case. An abstract is not available for this product.Desde 5,74 €
-
Palm (C): 2005
Casadesus-Masanell, Ramon; Boudreau, Kevin; Mitchell, JordanCaso HBS-708516-EThis case series looks at three important inflection points in Palm's history that relate to decisions about its platform: when the company was debating whether to open its operating system (OS) for licensing to third-party hardware manufacturers; 2001, when the company was deciding whether to split into two separate companies; and, 2005, when the company was migrating from its own OS into Linux. (The last part, set in 2008, is an epilogue). By l...Desde 5,74 €
-
Keroche (E): Considering Additional Capacity
Casadesus-Masanell, Ramon; Armerding, Pippa TubmanCaso HBS-720394-EDirección estratégicaThis case describes Keroche's growth after entering the beer business in 2008. Although the company was operating at full capacity and not able to fulfill all of its orders, Tabitha Karanja had set a goal of growing Keroche's share of the Kenyan beer market from slightly over 1% to 20%. In 2010, Tabitha Karanja had invested US$2.5 million in a PET bottling line to increase capacity of Keroche's vodka drinks. However, in 2010, the government had p...Desde 5,74 €